© 2022 MJH Life Sciences and Oncology Nursing News. All rights reserved.
© 2022 MJH Life Sciences™ and Oncology Nursing News. All rights reserved.
April 12, 2022
Evolving technology and adaptability allow for a more patient-centric approach to clinical trials; however, there are some limitations.
February 17, 2022
A City of Hope expert underscores the benefit of using antibody-drug conjugates, CDK4/6 inhibitors, PARP inhibitors, and checkpoint blockade in early-stage and metastatic breast cancer.
February 09, 2022
The COVID-19 pandemic has affected oncology practice in many ways. What will safe treating look like moving forward?
November 20, 2021
The majority of patients who received telotristat ethyl to treat their carcinoid syndrome reported stable or increased weight at a 6-month follow-up.